
--- Page 1 ---
IcD-O-3 Site: Brsst NDs c50.9 Procedure Date: Procedure Physician:e Attending Physician/Copies To: UUID:809F294F-8C48-4719-866B-7169FB1CE24D PATIENT HISTORY:E TCGA-BH-A1EN-01A-PR Redacted + DATE Or LMP: * DATE OF LAST DELIVERY: PRE-OP DIAGROSIS: RT BR CA POST-OP DIAGMOSIS: SAME OPERATIVE PROCEDURR: RT SEG MAST CLINICAL HISTORY: * MATERIAL SUBKITTED: RIGHT SEGMENTAL MASTECTOMY, PROCUREMENT BY SURGICAL PROCEDURES INTRAORERATIVE CONSULTATIOM: FROzeN sEcrion: Right breast mass; portion of breast, 7.0 by 4.0 by 3.5 cm with ellipse of skin, 7.0 by 1.0 cm. Lobulated maas, 4.0*by 2.0 by 2.0 cm. Margins grossly free.. Frozen Section and Touch Prep Diagnosis: Infiitrating carcinoma with signet ring features. rteSr JIAgNOSIS: RIGHT BREAST, :SEGXENTAL MASTECTONY: CLOSEST SURGICAL MARGINS ARE SUPSRIOR AND DEEP (LESS THAN 1 MOX)S - SURGICAL MARGINS ARE FRER OF TOXOR IM PLANES OF SECTIONS NOTE: eR/pR ixmunoperoxidase assay and Her-2/wru will bo performed on block Al.. SUPPLEMENTALREPORT ER/PR My signature below is attestation that I have raviewed all slides and agree with tho findings as noted below. INSUNOPEROXIDASE IDKNTIFICATION Or ESTROGKN AND PROCESTERONE RECEPTORS IS CARRIED OUT ON SLIDE A1. KO DISTINCT INTRANUCLEAR STAINING IS IDENTIFIED YOR SITHER RECEPTOR. THERKFORE. BOTH ARK INTERPRETED AS NEGATIVE. SOPPLEXENTALRBPORT HEr-2/g80 Ny signature below is attestation that I have reviewed all slides and agree with the findings as noted below. c-erbB2 (HER-2/NEU) IMOUNOSTAISING IS CARRIED OUT ON BLOCX A1 (BRKAST CANCER) USINC A 1:3CO DILUTIOR OF DAKO'S POLYCLONAL ANTIBODY A4SS (DIRECTED AGAINST THE INTRACELLULAR DOMAIN OF c-erbB2) WITEOUT ANTIGEN RETRIEVAL. DISTINCT CONPLETE MEMBRANS STAIWING IS IDENTIFIED IN GO% Or TOXOR CELLS. THEREFORE, C-erbB2 (HER- 2/NEU) IS INTERPRETED AS POSITIVE (SCORE 3+).